Ulf Wiinberg's most recent trade in MiNK Therapeutics Inc was a trade of 1,593 Common Stock done at an average price of $8.8 . Disclosure was reported to the exchange on March 3, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 8.79 per share. | 03 Mar 2025 | 1,593 | 16,007 | - | 8.8 | 14,002 | Common Stock |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.73 per share. | 01 Dec 2024 | 20,476 | 144,181 | - | 0.7 | 14,947 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 3,423 | 19,500 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.82 per share. | 03 Sep 2024 | 18,295 | 123,705 | - | 0.8 | 15,002 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 2,121 | 16,077 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.99 per share. | 03 Jun 2024 | 15,077 | 105,410 | - | 1.0 | 14,926 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 38,635 | 279,121 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 01 Mar 2024 | 15,790 | 90,333 | - | 1.0 | 15,001 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 5,000 | 5,000 | - | - | Stock Option | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 30,956 | 240,485 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 01 Dec 2023 | 14,424 | 74,543 | - | 1.0 | 15,001 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jul 2023 | 16,018 | 191,528 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 11,901 | 175,510 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 2.09 per share. | 01 Mar 2023 | 6,699 | 42,751 | - | 2.1 | 14,001 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 9,893 | 163,608 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 2.61 per share. | 01 Dec 2022 | 5,364 | 36,052 | - | 2.6 | 14,000 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 9,862 | 153,714 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 2.62 per share. | 15 Sep 2022 | 10,688 | 10,688 | - | 2.6 | 28,003 | Common Stock |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 18 Jul 2022 | 16,661 | 298,300 | - | 1.4 | 23,209 | Common Stock |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Purchase of securities on an exchange or from another person at price $ 1.33 per share. | 18 Jul 2022 | 3,339 | 281,639 | - | 1.3 | 4,438 | Common Stock |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 13,854 | 143,852 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 9,307 | 129,997 | - | - | Deferred Stock Units | |
MiNK Therapeutics Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 6,391 | 120,689 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 4,451 | 114,297 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 16,853 | 99,063 (0%) | 0% | - | Common Stock | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 100,000 | 100,000 | - | - | Stock Option | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 6,707 | 109,846 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 6,959 | 110,098 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 5,896 | 96,179 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2020 | 100,000 | 100,000 | - | - | Stock Option (Right to buy) | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 6,464 | 90,282 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 8,398 | 83,817 | - | - | Deferred Stock Units | |
Agenus Inc | Ulf Wiinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 20,338 | 82,210 (0%) | 0% | - | Common Stock | |
Agenus Inc | Ulf Wiinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jun 2020 | 20,338 | 0 | - | - | Restricted Stock Unit | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 16,853 | 37,191 | - | - | Restricted Stock Unit | |
Agenus Inc | Ulf Wiinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 8,009 | 75,419 | - | - | Deferred Stock Units |